ⓘ Featured image: Dr Mohit Misra, CEO & founder of Mango Sciences
The UAE-based Mango Sciences, a healthtech startup company that focuses on emerging markets, on 30 September 2020 raised an undisclosed amount of funding from UAE’s Spartech Ventures.
Launched in January 2019 by Dr Mohit Misra, Mango Sciences helps tackle access to precision medicine for populations overlooked in emerging markets. The company uses artificial intelligence to better understand the cost of care, improve operational efficiencies and enable personalised care for all populations through partnering with hospitals and clinics in Asia and the Middle East to unlock underutilised health insights from complex clinical data.
Speaking profoundly of the backing of Mango Sciences, Amer Fatayer, managing director of Spartech Ventures, in a statement said,
“We are excited about how Mango’s data platform can transform care delivery for people in the GCC, catalysing clinical research and access to truly personalised care for everyone,”
Commenting on the key-proposition of Mango Sciences, Dr Mohit Misra, the CEO of Mango Sciences, said,
“Mango’s unique ability to collaborate across the healthcare ecosystem allows us to leverage data to identify unmet need and help finance innovative immunotherapies for patients where affordability is a key issue to access,”
According to Crunchbase, the latest backing for Mango Sciences comes as the third funding round, since the company previously raised $2.7 million in January 2020, and $750,000 in July 2020 from undisclosed investors.
